Utility of the Biomarker CA125 in the Diagnosis of Cellular Rejection in Allogeneic Heart Transplantation. Lopez-Vilella R, Sanchez-Lazaro I, Aguado C, Franch NM, et al. Transplant Proc 2021 Sep 30. pii: S0041-1345(21)00626.

Read + Share

Amedeo Smart

Independent Medical Education

Lopez-Vilella R, Sanchez-Lazaro I, Aguado C, Franch NM, et al. Utility of the Biomarker CA125 in the Diagnosis of Cellular Rejection in Allogeneic Heart Transplantation. Transplant Proc 2021 Sep 30. pii: S0041-1345(21)00626.
PMID: 34600758